Data as of Dec 10
| -0.08 / -0.94%|
The 3 analysts offering 12-month price forecasts for Depomed Inc have a median target of 10.00, with a high estimate of 11.00 and a low estimate of 9.00. The median estimate represents a +18.34% increase from the last price of 8.45.
The current consensus among 3 polled investment analysts is to Buy stock in Depomed Inc. This rating has held steady since November, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.